Notoginsenoside Ft1 Promotes Fibroblast Proliferation via PI3K/Akt/mTOR Signaling Pathway and Benefits Wound Healing in Genetically Diabetic Mice
- 1 February 2016
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 356 (2) , 324-332
Abstract
Wound healing requires the essential participation of fibroblasts, which is impaired in diabetic foot ulcers (DFU). Notoginsenoside Ft1 (Ft1), a saponin from Panax notoginseng, can enhance platelet aggregation by activating signaling network mediated through P2Y12 and induce proliferation, migration, and tube formation in cultured human umbilical vein endothelial cells. However, whether it can accelerate fibroblast proliferation and benefit wound healing, especially DFU, has not been elucidated. In the present study on human dermal fibroblast HDF-a, Ft1 increased cell proliferation and collagen production via PI3K/Akt/mTOR signaling pathway. On the excisional wound splinting model established on db/db diabetic mouse, topical application of Ft1 significantly shortened the wound closure time by 5.1 days in contrast with phosphate-buffered saline (PBS) treatment (15.8 versus 20.9 days). Meanwhile, Ft1 increased the rate of re-epithelialization and the amount of granulation tissue at day 7 and day 14. The molecule also enhanced mRNA expressions of COL1A1, COL3A1, transforming growth factor (TGF)-β1 and TGF-β3 and fibronectin, the genes that contributed to collagen expression, fibroblast proliferation, and consequent scar formation. Moreover, Ft1 facilitated the neovascularization accompanied with elevated vascular endothelial growth factor, platelet-derived growth factor, and fibroblast growth factor at either mRNA or protein levels and alleviated the inflammation of infiltrated monocytes indicated by reduced tumor necrosis factor-α and interleukin-6 mRNA expressions in the diabetic wounds. Altogether, these results indicated that Ft1 might accelerate diabetic wound healing by orchestrating multiple processes, including promoting fibroblast proliferation, enhancing angiogenesis, and attenuating inflammatory response, which provided a great potential application of it in clinics for patients with DFU.Keywords
This publication has 31 references indexed in Scilit:
- Advanced glycoxidation products and impaired diabetic wound healingWound Repair and Regeneration, 2009
- Wound repair and regenerationNature, 2008
- Cellular and molecular basis of wound healing in diabetesJournal of Clinical Investigation, 2007
- Endothelial Cell Migration During AngiogenesisCirculation Research, 2007
- Inflammation in Wound Repair: Molecular and Cellular MechanismsJournal of Investigative Dermatology, 2007
- New Dammarane Monodesmosides from the Acidic Deglycosylation of Notoginseng-Leaf SaponinsHelvetica Chimica Acta, 2006
- The myofibroblast in wound healing and fibrocontractive diseasesThe Journal of Pathology, 2003
- Tissue Engineering--Current Challenges and Expanding OpportunitiesScience, 2002
- Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings.Diabetes Care, 1999
- WOUND HEALING AND COLLAGEN FORMATIONJournal of Cell Biology, 1970